Amicus Filers Support Drugmakers’ Petition For Review Of Class Certification Case
WASHINGTON, D.C. — A pair of organizations representing business and biopharmaceutical research interests urged the U.S. Supreme Court to grant a petition for a writ of certiorari filed by two drug...To view the full article, register now.
Already a subscriber? Click here to view full article